Digestive Remedies in Australia

Abstract
Sales of digestive remedies in Australia are mainly driven by diarrhoeal remedies, IBS treatment and laxatives, with multiple factors influencing demand. These include lifestyles that comprise poor diet or lack of exercise, leading to one third of Australians struggling with chronic gastrointestinal symptoms, including abdominal pain, early satiety, bloating, constipation or diarrhoea, encouraging them to reach for accessible solutions such as digestive remedies to ease their discomfort.

Euromonitor International's Digestive Remedies in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Digestive Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Content
Digestive Remedies in Australia
January 2023

List Of Contents And Tables

DIGESTIVE REMEDIES IN AUSTRALIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Effects of COVID-19 help drive demand for diarrhoeal remedies
Unhealthy eating habits fuel growth of laxatives
Johnson & Johnson strengthens leadership of digestive remedies with wide product portfolio
PROSPECTS AND OPPORTUNITIES
Ageing demographic contributes to demand for digestive remedies
Threat of substitutes and healthier lifestyles can hinder stronger growth for digestive remedies
Slower rate of decline for H2 blockers but Australians now rely on alternatives
CATEGORY DATA
Table 1 Sales of Digestive Remedies by Category: Value 2017-2022
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Digestive Remedies: % Value 2018-2022
Table 4 LBN Brand Shares of Digestive Remedies: % Value 2019-2022
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2022-2027
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN AUSTRALIA
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2021-2022
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources